Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Oxana M. Tsygankova

Histone Deacetylase Is a Target of Valproic Acid-Mediated Cellular Differentiation

Cancer Research

Oncology

2004

English

Differential Signaling of Cyclic AMP

Journal of Biological Chemistry

English

Related publications

Histone Deacetylase Inhibitors Valproic Acid and Vorinostat Enhance Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Phagocytosis

Journal for ImmunoTherapy of Cancer

English

Histone Deacetylase 11 Is a Fatty-Acid Deacylase

English

Histone Deacetylase Inhibitor, Valproic Acid, Radiosensitizes the C6 Glioma Cell Line in Vitro

English

ΔNp63, a Target of DEC1 and Histone Deacetylase 2, Modulates the Efficacy of Histone Deacetylase Inhibitors in Growth Suppression and Keratinocyte Differentiation

Journal of Biological Chemistry

English

Histone Deacetylase Inhibitor Valproic Acid Enhances the Cytokine-Induced Expansion of Human Hematopoietic Stem Cells

Cancer Research

Oncology

2005

English

A Functional Genetic Screen Identifies Retinoic Acid Signaling as a Target of Histone Deacetylase Inhibitors

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

2007

English

Histone Deacetylase Inhibitor Valproic Acid Suppresses the Growth and Increases the Androgen Responsiveness of Prostate Cancer Cells

English

Histone Deacetylase Inhibition by Valproic Acid Down-Regulates C-Flip/Cash and Sensitizes Hepatoma Cells Towards CD95- And TRAIL Receptor-Mediated Apoptosis and Chemotherapy

English

Somatic Nucleus Reprogramming Is Significantly Improved Bym-Carboxycinnamic Acid Bishydroxamide, a Histone Deacetylase Inhibitor

Journal of Biological Chemistry

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Oxana M. Tsygankova

Histone Deacetylase Is a Target of Valproic Acid-Mediated Cellular Differentiation

Differential Signaling of Cyclic AMP

Related publications

Histone Deacetylase Inhibitors Valproic Acid and Vorinostat Enhance Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Phagocytosis

Histone Deacetylase 11 Is a Fatty-Acid Deacylase

Histone Deacetylase Inhibitor, Valproic Acid, Radiosensitizes the C6 Glioma Cell Line in Vitro

ΔNp63, a Target of DEC1 and Histone Deacetylase 2, Modulates the Efficacy of Histone Deacetylase Inhibitors in Growth Suppression and Keratinocyte Differentiation

Histone Deacetylase Inhibitor Valproic Acid Enhances the Cytokine-Induced Expansion of Human Hematopoietic Stem Cells

A Functional Genetic Screen Identifies Retinoic Acid Signaling as a Target of Histone Deacetylase Inhibitors

Histone Deacetylase Inhibitor Valproic Acid Suppresses the Growth and Increases the Androgen Responsiveness of Prostate Cancer Cells

Histone Deacetylase Inhibition by Valproic Acid Down-Regulates C-Flip/Cash and Sensitizes Hepatoma Cells Towards CD95- And TRAIL Receptor-Mediated Apoptosis and Chemotherapy

Somatic Nucleus Reprogramming Is Significantly Improved Bym-Carboxycinnamic Acid Bishydroxamide, a Histone Deacetylase Inhibitor